ClinicalTrials.Veeva

Menu

The SINCERE Intervention to Address COVID-19 Health Disparities

A

Andrea Wallace

Status

Enrolling

Conditions

COVID-19
Social Determinants of Health
Vulnerable Populations

Treatments

Behavioral: SINCERE
Other: Standard of Care
Behavioral: Scheduled Follow-Up

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05228886
00140301
1R01NR019944-01 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The goal of this real world efficacy study is to understand the benefit of universal social needs screening, community-based service referrals, and telephonic follow-up as a scalable strategy for preventing COVID-19 transmission, and for addressing the secondary health effects of the social, behavioral, and economic changes following the COVID-19 pandemic. With statewide community service providers, existing health information technology, and piloted methods, we seek to determine the effectiveness of universal social needs screening and community service referrals - the SINCERE intervention - in improving health outcomes of COVID-19 vulnerable and socioeconomically disadvantaged populations and whether intensive follow-up and collaborative goal-setting helps overcome barriers to community service use by patients seen in the emergency department and seeking COVID testing at community-based and mobile clinic locations.

Enrollment

1,500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adult (> 17 years)
  • English or Spanish speaking
  • Completed the referral process at the UHealth ED, one of the COVID-19 testing sites or the Primary Children's ED and indicated both social needs and willingness to receive service low- and no-cost referrals from the United Way 211 community referral service
  • Able to be reached by phone during the intervention OR able to complete surveys sent by text or email

Exclusion criteria

  • Those unable to communicate verbally
  • Those living in nursing facilities, or those who are not otherwise responsible for self-care

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

1,500 participants in 3 patient groups

Call + Resources
Active Comparator group
Description:
Participants receive standard care typically provided to 211 callers, including ad hoc follow-up.
Treatment:
Other: Standard of Care
Call + Resources + Scheduled Follow-Up
Experimental group
Description:
Participants receive standard care typically provided to 211 callers plus scheduled follow-up calls according to the Scheduled Follow-Up intervention description.
Treatment:
Behavioral: Scheduled Follow-Up
Call + Resources + SINCERE
Experimental group
Description:
Participants receive standard care typically provided to 211 callers plus scheduled follow-up calls according to the SINCERE intervention description (scheduled follow up with active collaborative goal setting).
Treatment:
Behavioral: SINCERE

Trial contacts and locations

1

Loading...

Central trial contact

Ernest Grigorian

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems